Loading…
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Use of Cardiac Troponin and B-Type Natriuretic Peptide or N-Terminal proB-Type Natriuretic Peptide for Etiologies Other than Acute Coronary Syndromes and Heart Failure
In the majority of these studies, cTnT or cTnI cutoff concentrations were higher than either the 99th percentile or the 10% CV value. These and other studies have consistently shown that postprocedural increases in cTn and/or CK-MB are associated with major adverse clinical events.
Saved in:
Published in: | Clinical chemistry (Baltimore, Md.) Md.), 2007-12, Vol.53 (12), p.2086-2096 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | In the majority of these studies, cTnT or cTnI cutoff concentrations were higher than either the 99th percentile or the 10% CV value. These and other studies have consistently shown that postprocedural increases in cTn and/or CK-MB are associated with major adverse clinical events. |
---|---|
ISSN: | 0009-9147 1530-8561 |
DOI: | 10.1373/clinchem.2007.095679 |